AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Soiken Holdings Inc.
  3. Financials
  4. Revenue growth (%)

Soiken Holdings Inc.【JP:2385】

Market cap
¥6.3B
P/E ratio
210.4x
Soken Medical Holdings develops biomarker testing systems for food and pharmaceutical companies while selling health products directly to consumers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Jun 30, 2025-6-83.38%
Jun 30, 2024-36.2+166.67%
Jun 30, 2023-13.6-399.34%
Jun 30, 20224.5-214.11%
Jun 30, 2021-4-117.22%
Jun 30, 202023.1-40.50%
Jun 30, 201938.7+22.95%
Jun 30, 201831.5+8.32%
Jun 30, 201729.1+11.63%
Jun 30, 201626.1+196.47%
Jun 30, 20158.8-54.12%
Jun 30, 201419.2-28.98%
Jun 30, 201327+1342.78%
Jun 30, 20121.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)